Evidence map›Paper›PMID 21738680›Full record

ArticlePloS one2011

Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virus.

Steven Froelich, April Tai, Katie Kennedy, Adnan Zubair, Pin Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Surface (S) Layer Proteins ofFrontiers in microbiology · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Virus entry: old viruses, new receptors.Current opinion in virology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Steven FroelichMork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California, United States of America.
April Tai
Katie Kennedy
Adnan Zubair
Pin Wang
University of Southern California · US

Funding

Transduction of Hematopoietic Stem Cells for Enhanced Immunotherapy of MelanomaP01CA132681 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BALTIMORE, DAVID · 2010 to 2014
$14.4M
Targeting lentiviruses to infect chosen cellsR01AI068978 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, PIN · 2006 to 2010
$2.9M
NCI NIH HHS P01 CA132681NCI NIH HHS P01CA132681NIAID NIH HHS R01 AI068978NIAID NIH HHS R01AI68978
6 · The paper itself

Abstract

Lentiviruses have recently attracted considerable interest for their potential as a genetic modification tool for dendritic cells (DCs). In this study, we explore the ability of lentiviruses enveloped with alphaviral envelope glycoproteins derived from Semliki Forest virus (SFV) to mediate transduction of DCs. We found that SFV glycoprotein (SFV-G)-pseudotyped lentiviruses use C-type lectins (DC-SIGN and L-SIGN) as attachment factors for transduction of DCs. Importantly, SFV-G pseudotypes appear to have enhanced transduction towards C-type lectin-expressing cells when produced under conditions limiting glycosylation to simple high-mannose, N-linked glycans. These results, in addition to the natural DC tropism of SFV-G, offer evidence to support the use of SFV-G-bearing lentiviruses to genetically modify DCs for the study of DC biology and DC-based immunotherapy.

Indexed as

Cell LineCells, CulturedDendritic CellsGlycoproteinsHumansLentivirusPlasmidsReceptors, VirusSemliki forest virusTransduction, GeneticViral Envelope ProteinsGlycoproteinsReceptors, VirusViral Envelope Proteins

Identifiers

PMID21738680
PMCPMC3124512
OpenAlexW2126040408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.